|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 2468770 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11192705.9 |
| Date of filing the European patent application | 2007-07-13 | |
| (97) | Date of publication of the European application | 2012-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-20 |
| (46) | Date of publication of the claims translation | 2018-05-25 |
| (30) | Number | Date | Country code |
| 94328907 P | 2007-06-11 | US | |
| 94349907 P | 2007-06-12 | US | |
| 06014730 | 2006-07-14 | EP | |
| 06020765 | 2006-10-02 | EP |
| (72) |
Pfeifer, Andrea, CH
Pihlgren Bosch, Maria, CH
Muhs, Andreas, CH
Watts, Ryan, US
|
| (73) |
AC Immune S.A.,
EPFL Innovation Park Building B, 1015 Lausanne,
CH
Genentech, Inc., One DNA Way, South San Francisco, CA 94080-4990, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Humanizuotas antikūnas prieš beta amiloidą |
| Humanized antibody against amyloid beta. |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 19 | 347.00 EUR |
| 2026-07-13 |